Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.2K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.2K
Methods of Medium Optimization01:28

Methods of Medium Optimization

63
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
63
Persuasion Strategies01:52

Persuasion Strategies

44.0K
Researchers have tested many persuasion strategies, including the foot-in-the door and the door-in-the-face techniques, in a variety of contexts. Ultimately, the principles are effective in selling products and changing people’s attitude, ideas, and behaviors (Cialdini & Goldstein, 2004).
44.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the determinants of public trust in the health care system in China: an analysis of a cross-sectional survey.

Journal of health services research & policy·2018
Same author

Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth.

The Journal of pediatrics·2018
Same author

Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome.

Biometrics·2018
Same author

LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.

Pathology, research and practice·2018
Same author

International variations in trust in health care systems.

The International journal of health planning and management·2018
Same author

Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes.

Diabetologia·2018
Same journal

Why Next-generation mechanistic models Will transform drug discovery: integrating efficacy and safety.

Expert opinion on drug discovery·2026
Same journal

Toward a nuanced framework for the Medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

A Facile and Eco-friendly Route to Fabricate PolyLactic Acid Scaffolds with Graded Pore Size
13:46

A Facile and Eco-friendly Route to Fabricate PolyLactic Acid Scaffolds with Graded Pore Size

Published on: October 17, 2016

9.2K

Privileged scaffolds in lead generation.

Hongyu Zhao1, Justin Dietrich

  • 1AbbVie Inc., Research and Development , 1 North Waukegan Road, North Chicago, IL 60064 , USA +1 847 935 4566 ; hongyu.zhao@abbvie.com.

Expert Opinion on Drug Discovery
|May 12, 2015
PubMed
Summary
This summary is machine-generated.

Privileged scaffolds, initially designed for high-affinity ligands, are now integral to drug discovery platforms. While less critical for direct ligand identification due to advanced screening, their core principles enhance modern lead generation strategies.

Keywords:
binding warheadshigh-throughput screeningmultiple ligandsprivileged scaffoldprotein-protein interactions

More Related Videos

Elastomeric PGS Scaffolds in Arterial Tissue Engineering
08:35

Elastomeric PGS Scaffolds in Arterial Tissue Engineering

Published on: April 8, 2011

16.3K
Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
05:49

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

13.9K

Related Experiment Videos

Last Updated: Apr 12, 2026

A Facile and Eco-friendly Route to Fabricate PolyLactic Acid Scaffolds with Graded Pore Size
13:46

A Facile and Eco-friendly Route to Fabricate PolyLactic Acid Scaffolds with Graded Pore Size

Published on: October 17, 2016

9.2K
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
08:35

Elastomeric PGS Scaffolds in Arterial Tissue Engineering

Published on: April 8, 2011

16.3K
Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
05:49

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

13.9K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • The concept of privileged scaffolds emerged in 1988, aiming to create ligands binding multiple receptors.
  • This strategy has evolved from a standalone technology to a key component in lead generation.

Purpose of the Study:

  • To review the applications of privileged scaffolds in contemporary drug lead generation.
  • To highlight the strategic value of privileged scaffolds in various lead generation platforms.

Main Methods:

  • Review of privileged scaffold applications in lead generation.
  • Discussion of roles in high-throughput screening (HTS) compound production.
  • Analysis of applications in designing ligands for protein-protein interactions, multiple targets, and warhead-based approaches.

Main Results:

  • Privileged scaffolds are abundant in chemical space.
  • Their direct relevance for identifying high-affinity ligands has decreased due to advanced screening methods and larger compound libraries.
  • The underlying principles of privileged scaffolds significantly enhance current lead generation technologies.

Conclusions:

  • The strategic value of privileged scaffolds has shifted but remains crucial.
  • These scaffolds empower modern drug discovery platforms, particularly in lead generation.
  • The concept continues to influence the design of novel therapeutic agents.